Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): Study protocol for a randomized sham-controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Arbel, Yaron ^a   Ben Assa, Eyal ^a   Halkin, Amir ^a   Keren, Gad ^a   Schwartz, Arie L ^a   Havakuk, Ofer ^a   Leshem Rubinow, Eran ^a   Konigstein, Maayan ^a   Steinvil, Arie ^a   Abramowitz, Yigal ^a   Finkelstein, Ariel ^a   Banai, Shmuel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; FUROSEMIDE; SODIUM CHLORIDE; ANTIOXIDANT; CONTRAST MEDIUM; DIURETIC AGENT;

ACUTE KIDNEY FAILURE; AGED; AORTA STENOSIS; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE SAFETY; DIURESIS; DOUBLE BLIND PROCEDURE; FOLEY BALLOON CATHETER; HUMAN; HYDRATION; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; PROTECTIVE EQUIPMENT; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENALGUARD SYSTEM; TRANSCATHETER AORTIC VALVE IMPLANTATION; URINARY CATHETER; UROLOGICAL THERAPEUTIC DEVICE; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; BLADDER CATHETERIZATION; CHEMICALLY INDUCED; CLINICAL PROTOCOL; DRUG ADMINISTRATION; DRUG EFFECTS; FLUID THERAPY; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; ISRAEL; METHODOLOGY; PROCEDURES; TIME; TREATMENT OUTCOME;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; ANTIOXIDANTS; CARDIAC CATHETERIZATION; CLINICAL PROTOCOLS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DIURESIS; DIURETICS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FLUID THERAPY; FUROSEMIDE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; ISRAEL; RESEARCH DESIGN; SODIUM CHLORIDE; TIME FACTORS; TREATMENT OUTCOME; URINARY CATHETERIZATION;

EID: 84903402346     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-262     Document Type: Article

References (20)

1. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004, 44:1780-1785. 10.1016/j.jacc.2004.07.043, 15519007.
2. Bartorelli AL, Marenzi G. Contrast-induced nephropathy. J Interv Cardiol 2008, 21:74-85. 10.1111/j.1540-8183.2007.00318.x, 18086132.
3. Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, Golia B, Ricciardelli B, Condorelli G, Investigators RI. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation 2011, 124:1260-1269. 10.1161/CIRCULATIONAHA.111.030759, 21844075.
4. Marenzi G, Ferrari C, Marana I, Assanelli E, De Metrio M, Teruzzi G, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC Cardiovasc Interv 2012, 5:90-97. 10.1016/j.jcin.2011.08.017, 22230154.
5. Elhmidi Y, Bleiziffer S, Piazza N, Hutter A, Opitz A, Hettich I, Kornek M, Ruge H, Brockmann G, Mazzitelli D, Lange R. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 2011, 161:735-739. 10.1016/j.ahj.2011.01.009, 21473973.
6. Khawaja MZ, Thomas M, Joshi A, Asrress KN, Wilson K, Bolter K, Young CP, Hancock J, Bapat V, Redwood S. The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. Euro Interv 2012, 8:563-570.
7. Nuis RJ, Van Mieghem NM, Tzikas A, Piazza N, Otten AM, Cheng J, van Domburg RT, Betjes M, Serruys PW, de Jaegere PP. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2011, 77:881-889. 10.1002/ccd.22874, 21061244.
8. Podolecka E, Chmielak Z, Demkow M, Michalek P, Ksiezycka-Majczynska E, Chojnowska SL, Hryniewiecki T, Kusmierski K, Juraszynski Z, Czerwinska K, Sitkowska-Rysiak E, Ste{ogonek}pińska J, Rużyłło W, Witkowski A. Does contrast agent injection during trans-catheter aortic valve implantation negatively affect kidney function?. Kardiol Pol 2011, 69:251-255.
9. Saia F, Ciuca C, Taglieri N, Marrozzini C, Savini C, Bordoni B, Dall'ara G, Moretti C, Pilato E, Martin-Suarez S, Petridis FD, Di Bartolomeo R, Branzi A, Marzocchi A. Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. Int J Cardiol 2013, 168:1034-1040. 10.1016/j.ijcard.2012.10.029, 23164594.
10. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011, 32:205-217. 10.1093/eurheartj/ehq406, 3021388, 21216739.
11. Genereux P, Kodali SK, Green P, Paradis JM, Daneault B, Rene G, Hueter I, Georges I, Kirtane A, Hahn RT, Smith C, Leon MB, Williams MR. Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. Am J Cardiol 2013, 111:100-105. 10.1016/j.amjcard.2012.08.057, 3703857, 23040657.
12. Nuis RJ, Rodes-Cabau J, Sinning JM, van Garsse L, Kefer J, Bosmans J, Dager AE, van Mieghem N, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Dumont E, van Domburg RT, de Jaegere PP. Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2012, 5:680-688. 10.1161/CIRCINTERVENTIONS.112.971291, 23048055.
13. Sinning JM, Ghanem A, Steinhauser H, Adenauer V, Hammerstingl C, Nickenig G, Werner N. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010, 3:1141-1149. 10.1016/j.jcin.2010.09.009, 21087750.
14. Barbash IM, Ben-Dor I, Dvir D, Maluenda G, Xue Z, Torguson R, Satler LF, Pichard AD, Waksman R. Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. Am Heart J 2012, 163:1031-1036. 10.1016/j.ahj.2012.01.009, 22709757.
15. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2013, 145:6-23. 10.1016/j.jtcvs.2012.09.002, 23084102.
16. Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, Masson JB, Gutierrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodés-Cabau J. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010, 31:865-874. 10.1093/eurheartj/ehp552, 2848323, 20037180.
17. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011, 57:253-269. 10.1016/j.jacc.2010.12.005, 21216553.
18. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992, 62:413-415. 10.1159/000187090, 1300436.
19. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994, 331:1416-1420. 10.1056/NEJM199411243312104, 7969280.
20. Konigstein M, Ben-Assa E, Abramowitz Y, Steinvil A, Leshem Rubinow E, Havakuk O, Arbel Y, Halkin A, Keren G, Banai S, Finkelstein A. Usefulness of Updated Valve Academic Research Consortiume 2 Criteria for Acute Kidney Injury Following Transcatheter Aortic Valve Implantation. Am J Car 2013, 112:1807-1811.